INS and polycystic ovary syndrome: The beneficial effects of insulin sensitizer therapies in enhancing insulin sensitivity and improving ovulatory function in women with PCOS [47, 48] may relate to normalization of intrafollicular steroidal milieu, as evidenced in the T + R animals.